Wenjing J. Luo
No. 600 Tianhe Road
Guangzhou, 510630, China
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Adjunctive gypenosides for acute optic neuritis: A prematurely terminated randomized, double-blind, placebo-controlled pilot trial in a cohort with frequent AQP4-IgG positivity.
Journal: Multiple sclerosis and related disorders
Published: April 07, 2026
Meningoencephalitis and tumefactive demyelination are dominant factors for headaches in myelin oligodendrocyte glycoprotein antibody-associated disease.
Journal: Multiple sclerosis and related disorders
Published: March 08, 2026
Painful tonic spasms in neuromyelitis optica spectrum disorders: Prevalence, clinical phenotype, symptomatic management, and patient-reported burden in a Chinese cohort.
Journal: Multiple sclerosis and related disorders
Published: January 23, 2026
Translation and preliminary validation of a Chinese version of a short dry eye symptom questionnaire.
Journal: Frontiers in medicine
Published: December 15, 2025
Diagnostic yield of the 2022 optic neuritis criteria and an antibody-stratified adjunct in an antibody-predominant Chinese clinical sample.
Journal: Multiple sclerosis and related disorders
Published: December 15, 2025
A Review of Receptor Recognition Mechanisms in Coronaviruses.
Journal: Viruses
Published: November 04, 2025
Elevated serum complement shows promise as a potential clinically practical biomarker for disease activity in myelin oligodendrocyte glycoprotein antibody-associated disorders.
Journal: Multiple sclerosis and related disorders
Published: October 28, 2025
The IL-1β-STING Signaling Axis Drives Neuromyelitis Optica Pathogenesis in a Murine Model.
Journal: Annals of neurology
Published: October 05, 2025
Optic nerve involvement in multiple sclerosis diagnosis.
Journal: The Lancet. Neurology
Published: September 27, 2025
External validation of the MOG-AR score for predicting post-attack relapse risk in a chinese cohort with MOGAD.
Journal: Multiple sclerosis and related disorders
Published: June 09, 2025
CFHR2 supplementation mitigates pathologies of neuromyelitis optica by regulating complement activation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 16, 2025
Association of relapses with visual outcomes in optic neuritis: a post hoc analysis of the Optic Neuritis Treatment Trial.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: July 11, 2024
Last Updated: 09/26/2026